The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Effect of Osteoporosis Treatment on Mortality: A Meta-Analysis
Open accessAbstract
CONTEXT: Fragility fractures cause significant morbidity and mortality. Effective osteoporosis treatment can reduce fracture incidence, but it is not known whether it reduces mortality. OBJECTIVE: The aim of the study was to determine whether effective osteoporosis treatment reduces mortality. DATA SOURCES: We searched Medline and the Cochrane Central Register of Trials prior to September 2008, as well as 2000-2008 American Society for Bone and Mineral Research conference abstracts. STUDY SELECTION: Eligible studies were randomized placebo-controlled trials of approved doses of medications with proven efficacy in preventing both vertebral and nonvertebral fractures, in which the study duration was longer than 12 months and there were more than 10 deaths. Trials of estrogen and selective estrogen receptor modulators were specifically excluded. DATA EXTRACTION: Data were extracted from the text of the retrieved articles, published meta-analyses, or the Food and Drug Administration web site. DATA SYNTHESIS: Eight eligible studies of four agents (risedronate, strontium ranelate, zoledronic acid, and denosumab) were included in the primary analysis. During two alendronate studies, the treatment dose changed, and those studies were only included in secondary analyses. In the primary analysis, treatment was associated with an 11% reduction in mortality (relative risk, 0.89; 95% confidence interval, 0.80-0.99; P = 0.036). In the secondary analysis, the results were similar (relative risk, 0.90; 95% confidence interval, 0.81-1.0; P = 0.044). Mortality reduction was not related to age or incidence of hip or nonvertebral fracture, but was greatest in trials conducted in populations with higher mortality rates. CONCLUSIONS: Treatments for osteoporosis with established vertebral and nonvertebral fracture efficacy reduce mortality in older, frailer individuals with osteoporosis who are at high risk of fracture.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
Neer, R. M., Arnaud, C. D., Zanchetta, J. R., Prince, R., Gaich, G. A., Reginster, J.-Y., Hodsman, A. B., Eriksen, E. F., Ish-Shalom, S., Genant, H. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441904 · Cited by 4,602
Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Cummings, S. R., Martin, J. S., McClung, M. R., Siris, E. S., Eastell, R., Reid, I. R., Delmas, P., Zoog, H. B., Austin, M., Wang, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809493 · Cited by 3,489
Self-citationOnce-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis
Black, D. M., Delmas, P. D., Eastell, R., Reid, I. R., Boonen, S., Cauley, J. A., Cosman, F., Lakatos, P., Leung, P. C., Man, Z., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067312 · Cited by 2,986
Self-citationZoledronic Acid and Clinical Fractures and Mortality after Hip Fracture
Lyles, K. W., Colón-Emeric, C. S., Magaziner, J. S., Adachi, J. D., Pieper, C. F., Mautalen, C., Hyldstrup, L., Recknor, C., Nordsletten, L., Moore, K. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa074941 · Cited by 2,003 · cited 5×
“2 deaths per 1000 patientyears) (4, 15, 16, 18), there was a significant reduction in mortality (RR, 0.”
BackgroundInfluentialMortality after all major types of osteoporotic fracture in men and women: an observational study
Center, J. R., Nguyen, T. V., Schneider, D., Sambrook, P. N., & Eisman, J. A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09075-8 · Cited by 1,926
Effect of Risedronate on the Risk of Hip Fracture in Elderly Women
McClung, M. R., Geusens, P., Miller, P. D., Zippel, H., Bensen, W. G., Roux, C., Adami, S., Fogelman, I., Diamond, T., Eastell, R., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102013440503 · Cited by 1,918
Bliuc, D. (2009) · JAMA · doi:10.1001/jama.2009.50 · Cited by 1,699
Meunier, P. J., Roux, C., Seeman, E., Ortolani, S., Badurski, J. E., Spector, T. D., Cannata, J., Balogh, A., Lemmel, E.-M., Pors-Nielsen, S., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa022436 · Cited by 1,638
Reginster, J.-Y., Minne, H. W., Sorensen, O. H., Hooper, M., Roux, C., Brandi, M. L., Lund, B., Ethgen, D., Pack, S., Roumagnac, I., et al. (2000) · Osteoporosis International · doi:10.1007/s001980050010 · Cited by 1,580
The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis
Staa, T. P. V., Staa, T. P. V., Staa, T. P. V., Leufkens, H. G. M., & Cooper, C. (2002) · Osteoporosis International · doi:10.1007/s001980200108 · Cited by 1,294
Chesnut, C. H., Skag, A., Christiansen, C., Recker, R., Stakkestad, J. A., Hoiseth, A., Felsenberg, D., Huss, H., Gilbride, J., Schimmer, R. C., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040325 · Cited by 1,229
Sambrook, P., & Cooper, C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68891-0 · Cited by 1,165
Reginster, J. Y., Seeman, E., De Vernejoul, M. C., Adami, S., Compston, J., Phenekos, C., Devogelaer, J. P., Curiel, M. D., Sawicki, A., Goemaere, S., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1774 · Cited by 1,071
Effects of Raloxifene on Cardiovascular Events and Breast Cancer in Postmenopausal Women
Barrett-Connor, E., Mosca, L., Collins, P., Geiger, M. J., Grady, D., Kornitzer, M., McNabb, M. A., & Wenger, N. K. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062462 · Cited by 1,048
Risk of Mortality Following Clinical Fractures
Cauley, J. A., Thompson, D. E., Ensrud, K. C., Scott, J. C., & Black, D. (2000) · Osteoporosis International · doi:10.1007/s001980070075 · Cited by 947
EFFECT OF RISEDRONATE ON THE RISK OF HIP FRACTURE IN ELDERLY WOMEN
Lung, R. M. C. C., Eusens, P. I. G., Aul, P., Iller, D. M., Ippel, H. A. Z., Ensen, W. I. G. B., Oux, C. H. R., Dami, S. I. A., Ogelman, I. G. F., Astell, R. I. E., et al. (2001) · Cited by 682
IX: Summary of Meta-Analyses of Therapies for Postmenopausal Osteoporosis
Cranney, A., Guyatt, G., Griffith, L., Wells, G., Tugwell, P., Rosen, C., The Osteoporosis Methodology Group, & The Osteoporosis Research Advisory Group (2002) · Endocrine Reviews · doi:10.1210/er.2001-9002 · Cited by 604
The components of excess mortality after hip fracture
Kanis, J. A., Oden, A., Johnell, O., De Laet, C., Jonsson, B., & Oglesby, A. K. (2003) · Bone · doi:10.1016/s8756-3282(03)00061-9 · Cited by 549
MacLean, C., Newberry, S., Maglione, M., McMahon, M., Ranganath, V., Suttorp, M., Mojica, W., Timmer, M., Alexander, A., McNamara, M., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-3-200802050-00198 · Cited by 529
Stress-Response Hormesis and Aging: “That which Does Not Kill Us Makes Us Stronger”
Gems, D., & Partridge, L. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.01.001 · Cited by 498
Rattan, S. I. S. (2008) · Ageing Research Reviews · doi:10.1016/j.arr.2007.03.002 · Cited by 498
Elliot-Gibson, V., Bogoch, E. R., Jamal, S. A., & Beaton, D. E. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1675-5 · Cited by 426
Chesnut, C. H., McClung, M. R., Ensrud, K. E., Bell, N. H., Genant, H. K., Harris, S. T., Singer, F. R., Stock, J. L., Yood, R. A., Delmas, P. D., et al. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80134-x · Cited by 365
Meunier, P. J. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.5.2060 · Cited by 337
Fragility Fractures and the Osteoporosis Care Gap: An International Phenomenon
Giangregorio, L., Papaioannou, A., Cranney, A., Zytaruk, N., & Adachi, J. D. (2006) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2005.11.001 · Cited by 326
Mortality Following Fractures in Older Women: The Study of Osteoporotic Fractures
Browner, W. S. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440130053006 · Cited by 296
Excess mortality after hospitalisation for vertebral fracture
Kanis, J. A., Oden, A., Johnell, O., De Laet, C., & Jonsson, B. (2004) · Osteoporosis International · doi:10.1007/s00198-003-1516-y · Cited by 290
McCloskey, E. V., Beneton, M., Charlesworth, D., Kayan, K., de Takats, D., Dey, A., Orgee, J., Ashford, R., Forster, M., Cliffe, J., et al. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061008 · Cited by 200
Strontium ranelate for preventing and treating postmenopausal osteoporosis
O'Donnell, S., Cranney, A., Wells, G., Adachi, J., & Reginster, J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005326.pub3 · Cited by 179
Recker, R., Stakkestad, J. A., Chesnut, C. H., Christiansen, C., Skag, A., Hoiseth, A., Ettinger, M., Mahoney, P., Schimmer, R. C., & Delmas, P. D. (2004) · Bone · doi:10.1016/j.bone.2004.01.008 · Cited by 172
Potential mediators of the mortality reduction with zoledronic acid after hip fracture
Colón-Emeric, C. S., Mesenbrink, P., Lyles, K. W., Pieper, C. F., Boonen, S., Delmas, P., Eriksen, E. F., & Magaziner, J. (2010) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090704 · Cited by 159
Greenspan, S. L., Resnick, N. M., & Parker, R. A. (2003) · JAMA · doi:10.1001/jama.289.19.2525 · Cited by 156
McCloskey, E. V., Selby, P. L., Davies, M., Robinson, J., Francis, R. M., Adams, J. E., Kayan, K., Beneton, M. N. C., Jalava, T., Pylkkänen, L. H., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040116 · Cited by 145
Kalinowski, L., Dobrucki, L. W., Brovkovych, V. M., & Maliñski, T. (2002) · Circulation · doi:10.1161/hc0802.104283 · Cited by 134
Gerend, M. A., Aiken, L. S., West, S. G., & Erchull, M. J. (2004) · Health Psychology · doi:10.1037/0278-6133.23.3.247 · Cited by 133
Strontium ranelate for preventing and treating postmenopausal osteoporosis
O'Donnell, S., Cranney, A., Ga, W., Jd, A., & Reginster, J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005326.pub2 · Cited by 109
Cranney, A., Wells, G. A., Yetisir, E., Adámi, S., Cooper, C. C., Delmas, P. D., Miller, P. D., Papapoulos, S. E., Reginster, J., Sambrook, P. N., et al. (2008) · Osteoporosis International · doi:10.1007/s00198-008-0653-8 · Cited by 107
The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design
Hooven, F. H., Adachi, J. D., Adámi, S., Boonen, S., Compston, J. E., Cooper, C. C., Delmas, P. D., Díez‐Pérez, A., Gehlbach, S. H., Greenspan, S. L., et al. (2009) · Osteoporosis International · doi:10.1007/s00198-009-0958-2 · Cited by 103
Haentjens, P., Johnell, O., Kanis, J. А., Bouillon, R., Cooper, C. C., Lamraski, G., Vanderschueren, D., Kaufman, J., Boonen, S., & on behalf of the Network on Male Osteoporosis in Europe (NEMO) (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040917 · Cited by 102
Bonnick, S. L., Broy, S. B., Kaiser, F. E., Teutsch, C., Rosenberg, E., DeLucca, P. T., & Melton, M. E. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x188035 · Cited by 82
Reasons and risk: Factors underlying women's perceptions of susceptibility to osteoporosis
Gerend, M. A., Erchull, M. J., Aiken, L. S., & Maner, J. K. (2006) · Maturitas · doi:10.1016/j.maturitas.2006.03.003 · Cited by 64
Do patients perceive a link between a fragility fracture and osteoporosis?
Giangregorio, L., Παπαϊωάννου, Α., Thabane, L., DeBeer, J., Cranney, A., Dolovich, L. R., Adili, A. F., & Adachi, J. D. (2008) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-9-38 · Cited by 62
Palomba, S., Orio, F., Colao, A. A. L., Carlo, C. D., Sena, T., Lombardi, G., Zullo, F., & Mastrantonio, P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.4.8323 · Cited by 55
Perceived Risks and Reported Behaviors Associated with Osteoporosis and Its Treatment
Satterfield, T., Johnson, S. M., Slovic, P., Neil, N., & Schein, J. R. (2001) · Women & Health · doi:10.1300/j013v31n04_02 · Cited by 50
Osteoporosis beliefs and antiresorptive medication use
Cline, R. R., Farley, J. F., Hansen, R. A., & Schommer, J. C. (2004) · Maturitas · doi:10.1016/j.maturitas.2004.05.004 · Cited by 38
Dunn, B. K., & Ryan, A. M. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.03688.x · Cited by 28
Bisphosphonates may retrieve endothelial function in vascular diseases similar to statins’ effects
Ural, A. U., Avcu, F., & Öztürk, K. (2008) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2008.01068.x · Cited by 14
Zoledronate, Fractures, and Mortality after Hip Fracture
Lopez, C. A., & Tasneem, Z. (2008) · New England Journal of Medicine · doi:10.1056/nejmc073292 · Cited by 4
Cited by
Papaioannou, A., Morin, S., Cheung, A. M., Atkinson, S., Brown, J. P., Feldman, S., Hanley, D. A., Hodsman, A., Jamal, S. A., Kaiser, S. M., et al. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.100771 · Cited by 1,749
Bisphosphonates: The first 40years
Russell, R. G. G. (2011) · Bone · doi:10.1016/j.bone.2011.04.022 · Cited by 1,124
Adler, R. A., El-Hajj Fuleihan, G., Bauer, D. C., Camacho, P. M., Clarke, B. L., Clines, G. A., Compston, J. E., Drake, M. T., Edwards, B. J., Favus, M. J., et al. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2708 · Cited by 672
Ström, O., Borgström, F., Kanis, J. A., Compston, J., Cooper, C., McCloskey, E. V., & Jönsson, B. (2011) · Archives of Osteoporosis · doi:10.1007/s11657-011-0060-1 · Cited by 546
Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday
McClung, M., Harris, S. T., Miller, P. D., Bauer, D. C., Davison, K. S., Dian, L., Hanley, D. A., Kendler, D. L., Yuen, C. K., & Lewiecki, E. M. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.06.023 · Cited by 451
Metadata
- Authors
- Bolland, M. J., Grey, A. B., Gamble, G. D., & Reid, I. R.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2010-03-01
- Volume
- 95
- Issue
- 3
- Pages
- 1174-1181
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2155236480
- Cited by
- 329
- References
- 55
- FWCI
- 6.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.